RCM — R1 RCM Income Statement
0.000.00%
HealthcareAdventurousLarge Cap
- $6.04bn
- $8.09bn
- $2.25bn
Annual income statement for R1 RCM, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K/A | 10-K/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,186 | 1,271 | 1,475 | 1,806 | 2,254 |
Cost of Revenue | |||||
Gross Profit | 198 | 250 | 314 | 360 | 485 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,147 | 1,135 | 1,338 | 1,809 | 2,106 |
Operating Profit | 38.9 | 136 | 136 | -2.8 | 148 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 9.8 | 118 | 117 | -66.8 | 21 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12 | 117 | 87.3 | -63.3 | 3.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 12 | 117 | 87.3 | -63.3 | 3.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.7 | 47.4 | -505 | -63.3 | 3.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.236 | 0.318 | -1.76 | 0.156 | 0.169 |